New hope for lymphoma patients who have run out of options

NCT ID NCT07123454

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called AZD4512 for adults with B-cell non-Hodgkin lymphoma that has come back or stopped responding to at least two prior treatments. The main goals are to find a safe dose and see if the drug helps control the cancer. It will involve about 91 participants at multiple global sites.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Irvine, California, 92618, United States
Research Site
RECRUITING

Jacksonville, Florida, 32224, United States
Research Site
RECRUITING

Rochester, Minnesota, 55905, United States
Research Site
RECRUITING

New York, New York, 10016, United States
Research Site
RECRUITING

New York, New York, 10021, United States
Research Site
WITHDRAWN

Cleveland, Ohio, 44195, United States
Research Site
RECRUITING

Franklin, Tennessee, 37067, United States
Research Site
RECRUITING

Melbourne, 3000, Australia
Research Site
NOT_YET_RECRUITING

Chengdu, 610041, China
Research Site
NOT_YET_RECRUITING

Guangzhou, 510060, China
Research Site
RECRUITING

Bologna, 40138, Italy
Research Site
RECRUITING

Milan, 20133, Italy
Research Site
RECRUITING

Milan, 20141, Italy
Research Site
RECRUITING

Bunkyō City, 113-8677, Japan
Research Site
RECRUITING

Kōtoku, 135-8550, Japan
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 5505, South Korea
Research Site
NOT_YET_RECRUITING

Taichung, 40705, Taiwan
Research Site
RECRUITING

Taipei, 106, Taiwan
Research Site
RECRUITING

London, W1T 7HA, United Kingdom
Research Site
NOT_YET_RECRUITING

Newcastle upon Tyne, NE7 7DN, United Kingdom

Conditions

Explore the condition pages connected to this study.

B-CELL NON HODGKIN LYMPHOMA